Skip to content
Subcommittee on Crime and Drugs

Body Building Products and Hidden Steroids: Enforcement Barriers

Type: Full Committee Hearing
Date:
Time: 02:30pm
Location: Dirksen-226

Panel I

  • Richard Kingham

    Partner
    Covington & Burling LLP
    Washington, DC
  • Michael Levy

    Division Director, Office of Compliance, Center for Drug Evaluation and Research
    U.S. Food and Drug Administration
    Washington, DC
  • Joseph Rannazzisi

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration
    U.S. Department of Justice
    Washington, DC
  • Daniel Fabricant, Ph.D.

    Interim Executive Director and CEO, Vice President, Scientific & Regulatory Affairs
    National Products Association
    Washington, DC
  • Travis Tygart

    Chief Executive Officer
    United States Anti Doping Agency
    Colorado Springs, CO